Live Nation Entertainment, Inc. (LYV): debt financing — Live Nation closes $1.3B 2.875% convertible notes offering due 2031

Live Nation Entertainment, Inc.

Closed $1.3B 2.875% convertible notes due Oct 15, 2031; initial conversion price ~$224.93 (50% premium to $149.95 close).
Proceeds plus new credit facilities to redeem $1.3B of 5.625% 2026 notes and repay existing term loan and revolver.
Initial purchasers have 13-day option for additional $100M notes; total potential principal $1.4B.
Plans new credit facilities: $1.3B term loan B, $700M delayed-draw term loan A, $1.3B revolver, $400M venue revolver.
Issued conditional redemption notice for 2026 Notes on Nov 8, 2025, conditioned on receiving $302.4M gross proceeds.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Live Nation Entertainment, Inc. incurred convertible notes of $1.3 billion principal amount with HSBC Bank USA, National Association at 2.875% per annum maturing October 15, 2031.

Instrument: convertible notes
Principal: $1.3 billion principal amount
Counterparty: HSBC Bank USA, National Association
Rate: 2.875% per annum
Maturity: October 15, 2031
Event: incurrence

Exact text from the filing

On October 10, 2025, Live Nation Entertainment, Inc. (the "Company") closed its previously announced offering of $1.3 billion principal amount of 2.875% Convertible Senior Notes due 2031 (the "Notes").

View on SEC.gov

101 debt financings filed in the last 30 days. Browse all debt financings →

Live Nation Entertainment, Inc. filing history →

Source: SEC EDGAR

accession 0001335258-25-000137

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.